BBIO NASDAQ
BridgeBio Pharma, Inc.
1W: +0.9%
1M: -5.6%
3M: +3.1%
YTD: -10.2%
1Y: +108.5%
3Y: +398.8%
5Y: +31.0%
$69.12
-1.16 (-1.65%)
Weekly Expected Move ±6.1%
$58
$62
$66
$70
$74
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$580M
Revenue
+355.2% YoY
$-726M
Net Income
-8.7% YoY
$-454M
Free Cash Flow
+10.9% YoY
94.6%
Gross Margin
-54.5%
Op. Margin
-84.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE41.0%
ROA-78.3%
ROIC-697.2%
Valuation
P/E-18.5
P/B-5.9
EV/EBITDA-27.6
Leverage
Debt/Equity-1.31
Current Ratio2.62
Interest Cov.-5.3x
Quality Scores
Piotroski F3/9
Altman Z-3.77
Beneish M12.07